These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18226741)

  • 41. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Provider and center effect in multicenter randomized controlled trials of surgical specialties: an analysis on patient-level data.
    Biau DJ; Halm JA; Ahmadieh H; Capello WN; Jeekel J; Boutron I; Porcher R
    Ann Surg; 2008 May; 247(5):892-8. PubMed ID: 18438129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research.
    Takemoto SK; Arns W; Bunnapradist S; Garrison LP; Guirado L; Kalo Z; Oniscu G; Opelz G; Scolari MP; Stefoni S; Yaqoob M; Brennan DC
    Transplantation; 2008 Jul; 86(1):18-25. PubMed ID: 18622271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Research review boards dogged by criticism.
    Ledford H
    Nature; 2009 Apr; 458(7238):557. PubMed ID: 19340042
    [No Abstract]   [Full Text] [Related]  

  • 45. Psychotherapy and pharmacotherapy randomized controlled trials are equally likely to report a positive outcome.
    Faruqui RA; Ahmer S; Bhatti A; Faruqui A
    J Pak Med Assoc; 2008 Jan; 58(1):37-8. PubMed ID: 18297975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing communication among data monitoring committees and institutional review boards.
    Taylor HA; Chaisson L; Sugarman J
    Clin Trials; 2008; 5(3):277-82. PubMed ID: 18559418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis.
    Cook D; Sinuff T; Zytaruk N; Rabbat C; Lee A; O'Donnell M; Thabane L; Linkins L; Treleaven D; Patel R; Meade M; Crowther M; Marshall JC; Douketis J;
    J Crit Care; 2009 Jun; 24(2):168-75. PubMed ID: 19327956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 49. Fallacies in clinical cardiovascular trials.
    Swedberg K
    Heart; 2009 Sep; 95(17):1464-8. PubMed ID: 19684197
    [No Abstract]   [Full Text] [Related]  

  • 50. Commentary on Anand et al.
    Califf RM
    Clin Trials; 2011 Dec; 8(6):724-5; discussion 726. PubMed ID: 22167110
    [No Abstract]   [Full Text] [Related]  

  • 51. Commentary on Anand et al.
    DeMets DL
    Clin Trials; 2011 Dec; 8(6):722-3; discussion 726. PubMed ID: 22167109
    [No Abstract]   [Full Text] [Related]  

  • 52. Commentary on Anand et al.
    Dixon DO
    Clin Trials; 2011 Dec; 8(6):720-1; discussion 726. PubMed ID: 22167108
    [No Abstract]   [Full Text] [Related]  

  • 53. The new era of clinical research: using data for multiple purposes.
    Califf RM
    Am Heart J; 2014 Aug; 168(2):133-4. PubMed ID: 25066550
    [No Abstract]   [Full Text] [Related]  

  • 54. Interim monitoring of clinical trials.
    Richardson D
    Front Neurol Neurosci; 2009; 25():127-130. PubMed ID: 19478510
    [No Abstract]   [Full Text] [Related]  

  • 55. Scientific, societal, and economic consequences of releasing interim data from clinical trials.
    Sharma A; Bigelow RH; Pencina MJ
    Eur Heart J Qual Care Clin Outcomes; 2017 Jan; 3(1):9-10. PubMed ID: 28927189
    [No Abstract]   [Full Text] [Related]  

  • 56. When (not) to stop a clinical trial for benefit.
    Pocock SJ
    JAMA; 2005 Nov; 294(17):2228-30. PubMed ID: 16264167
    [No Abstract]   [Full Text] [Related]  

  • 57. Shedding light on data monitoring committee charters on ClinicalTrials.gov.
    Fine AM; Golfinopoulos E; Tse T
    Clin Trials; 2024 Apr; 21(2):260-261. PubMed ID: 37924275
    [No Abstract]   [Full Text] [Related]  

  • 58. Commentary on Fleming et al.: Data monitoring committee evidence base needed.
    Terrin M
    Clin Trials; 2017 Apr; 14(2):124-125. PubMed ID: 28142249
    [No Abstract]   [Full Text] [Related]  

  • 59. Are tight glycemic targets achieved through intensive insulin infusion still applicable in the intensive care unit?
    Can J Hosp Pharm; 2010 Jan; 63(1):51-4. PubMed ID: 22478956
    [No Abstract]   [Full Text] [Related]  

  • 60. A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.
    Fernandes RM; van der Lee JH; Offringa M
    BMC Pediatr; 2009 Dec; 9():77. PubMed ID: 20003383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.